Abnormal insulin response in patients with small-vessel disease

Area of Science:

• Endocrinology
• Vascular Biology
• Metabolic Research

Background:

• Small-vessel disease presents with ischemic lesions in the extremities, clinically resembling diabetic microangiopathy.
• Despite similar clinical presentations, small-vessel disease patients do not exhibit glucose intolerance.

Purpose of the Study:

• To investigate the insulin response to a glucose load in patients with small-vessel disease.
• To compare the insulin secretory capacity of small-vessel disease patients with healthy controls.

Main Methods:

• Twenty-five patients with small-vessel disease were administered a 50g oral glucose load.
• Insulin levels were measured before and after glucose administration.
• Tolbutamide stimulation test was also performed to assess insulin secretion.

Main Results:

• Patients with small-vessel disease demonstrated a markedly reduced insulin secretion in response to oral glucose.
• Insulin levels increased less than threefold in patients compared to a sixfold increase in controls.
• Nine out of twenty-five patients exhibited a flat insulin response curve throughout the test.
• Tolbutamide failed to stimulate insulin secretion in these patients.

Conclusions:

• Patients with small-vessel disease have a refractory state in insulin secretion, similar to juvenile diabetes mellitus.
• This impaired insulin response may play a role in the etiology of small-vessel disease lesions.
• Further research is warranted to elucidate the link between insulin secretion defects and vascular pathology.